Metropolitan Life Insurance Company (MetLife)’s indie Semiconductor INDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,677
Closed -$61.4K 1031
2024
Q1
$61.4K Hold
8,677
﹤0.01% 1298
2023
Q4
$70.4K Buy
8,677
+647
+8% +$4.22K ﹤0.01% 1264
2023
Q3
$50.6K Buy
8,030
+432
+6% +$3.34K ﹤0.01% 1397
2023
Q2
$71.4K Buy
7,598
+1,733
+30% +$15.6K ﹤0.01% 1209
2023
Q1
$61.9K Sell
5,865
-477
-8% -$4.26K ﹤0.01% 1274
2022
Q4
$37K Hold
6,342
﹤0.01% 1659
2022
Q3
$46.4K Hold
6,342
﹤0.01% 1508
2022
Q2
$36.1K Buy
+6,342
New +$43.7K ﹤0.01% 1701

Other funds holding INDI

Metropolitan Life Insurance Company (MetLife)'s INDI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of indie Semiconductor (INDI) in Q2 2024, closing a stake of 8,677 shares — an estimated $61.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INDI in Q2 2022 and held it in 8 quarters. The position peaked at $71.4K in Q2 2023. 185 funds tracked by Wall St. Rank hold INDI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining indie Semiconductor position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,677 indie Semiconductor shares in Q2 2024, an estimated $61.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in indie Semiconductor in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s indie Semiconductor position peaked at $71.4K in Q2 2023.
  • 185 funds tracked by Wall St. Rank held indie Semiconductor as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.